Menu
Translating VOC research into
innovative clinical applications
Translating VOC research into innovative clinical applications
We are a healthtech company transforming the huge potential of VOCs biomarkers into clinical applications for early cancer detection and precision medicine.
We are currently developing our wide multi-screening platform that covers the early detection of a broad range of cancer types, reducing cancer-associated mortality worldwide.
0
M
people die every year
from cancer
0
M
lives can be saved yearly
with early cancer detection
Every cancer has a VOC
signature called scent.
Every cancer has a VOC signature called scent.
A cancer scent can be detected at a very early stage, even before tumor growth.
Our Technology
Our current technology allows an early cancer detection of 7 types of cancer including colon, pancreas, melanoma, prostate, breast, ovaries, and bladder.
The patient can benefit from a fast and accurate screening of several cancer types at once, without pain or exposure to harmful radiation.
Early cancer detection is a right and a must.
Committing to a regular screening for early cancer detection can save your life and provide relief to your family and loved ones.
Get in touch
Vocoma AG
Oberneuhofstrasse 10,
6340 Baar, Switzerland
6340 Baar, Switzerland
Phone
Social
© Vocoma AG 2025. All rights reserved.
© Vocoma AG 2025. All rights reserved.